Trump’s ‘gift from God’ drug, espoused by Jewish doctor, does not prevent coronavirus: study

Hydroxychloroquine, the anti-malaria drug that some doctors are using to treat Covid-19. Image by Getty
Hydroxychloroquine, the anti-malaria drug touted by President Donald Trump as a treatment for Covid-19 — and taken by him to prevent contracting the disease — does not prevent against coronavirus infection when taken prophylactically, a new study found.
The study, published Wednesday in the New England Journal of Medicine, is the first double-blind, placebo-controlled study of the drug, meaning that neither the researchers administering the drug to research subjects, nor the subjects themselves, knew if they were taking hydroxychloroquine or a simple vitamin supplement. That methodology is considered the “gold standard” of medical research.
Dr. Vladimir Zelenko, a Hasidic doctor in New York who has made it his mission to promote the use of hydroxychloroquine to prevent hospitalization by using it to treat high-risk individuals with early symptoms, both criticized the study and touted the fact that it found that the drug is safe overall.
Zelenko’s approach, of prescribing hydroxychloroquine at the earliest signs of Covid-19 symptoms in high-risk individuals, is currently the subject of a controlled study at a hospital on Long Island, which will not release its results until next year.
Zelenko has advised other countries to use the drug prophylactically, however, and said that he took it himself to prevent infection, because he is immunocompromised.
The study’s subjects, who were mailed either the drug or the placebo immediately after being exposed to a Covid-19 patient, were front-line medical workers and first responders. Of the 821 people included in the study’s final results, 88% had high-risk exposures; 12% of the people taking hydroxychloroquine contracted the disease, compared with 14% of those taking the placebo. The study authors concluded that this was not a statistically meaningful difference.
The study did find that the drug, overall, is safe, citing no instances of serious side affects besides nausea and diarrhea. Previous analyses of observational data of hospitalized patients taking the drug found heightened risks of cardiac arrest compared with no use of the drug.
NEJM published misleading study. Only 3% patients had confirmed covid-19. Study managed completely online. Looks like they included many false positives. Study proves that HCQ safe. NO cardiac arrhythmia. TY NEJM. #ZelenkoProtocol @realDonaldTrump @RudyGiuliani @RonJohnsonWI
— Dr Vladimir (Zev) Zelenko (@zev_dr) June 4, 2020
Ari Feldman is a staff writer at the Forward. Contact him at [email protected] or follow him on Twitter @aefeldman
The Forward is free to read, but it isn’t free to produce

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
Readers like you make it all possible. We’ve started our Passover Fundraising Drive, and we need 1,800 readers like you to step up to support the Forward by April 21. Members of the Forward board are even matching the first 1,000 gifts, up to $70,000.
This is a great time to support independent Jewish journalism, because every dollar goes twice as far.
— Rachel Fishman Feddersen, Publisher and CEO
2X match on all Passover gifts!
Most Popular
- 1
News A Jewish Republican and Muslim Democrat are suddenly in a tight race for a special seat in Congress
- 2
Film & TV What Gal Gadot has said about the Israeli-Palestinian conflict
- 3
Fast Forward The NCAA men’s Final Four has 3 Jewish coaches
- 4
Culture How two Jewish names — Kohen and Mira — are dividing red and blue states
In Case You Missed It
-
Fast Forward Naftali Bennett is back: Former Israeli prime minister will make another run at Netanyahu
-
Fast Forward Citing post-Holocaust doctrine, Germany seeks to deport 4 pro-Palestinian protesters, including one American
-
Fast Forward Trump administration freezes research funding to Princeton amid antisemitism investigations
-
Fast Forward ‘Another Jewish warrior’: Fine wins special election for U.S. House seat
-
Shop the Forward Store
100% of profits support our journalism
Republish This Story
Please read before republishing
We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:
- Credit the Forward
- Retain our pixel
- Preserve our canonical link in Google search
- Add a noindex tag in Google search
See our full guidelines for more information, and this guide for detail about canonical URLs.
To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.